UNSPSC 51343103: Clevudine

This classification denotes a reverse transcriptase inhibitor with the molecular formula C10H13FN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IN51MVP5F1, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-beta-l-arabinofuranosyl)-5-methyl- but generally known as clevudine, which bears US NIH Compound Identifier 73115. European Medicines Agency schedules Clevudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06656MIG.

UNSPSC 51343103 Clevudine, a Commodity code, shows minimal recent state and local procurement activity directly tied to this specific antiviral pharmaceutical. The recent opportunities posted under this code primarily solicit naloxone, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals through cooperative purchasing, and prescription fulfillment programs—none of which are specifically clevudine-related products. State and local governments use UNSPSC pharmaceutical codes to classify medicines acquired for public health programs, emergency response systems, and centralized pharmacy benefit operations, but the activity under this particular code appears misaligned with its nominal scope or reflects administrative tagging rather than direct procurement of clevudine.

The issuing bodies include county health departments (Seminole County, Florida), municipal fire and rescue divisions (City of Tampa), state health and human services agencies (Texas HHS Commission), and cooperative purchasing alliances serving multi-state public sector networks (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP). Recent solicitations span Florida, Texas, Minnesota, and Oregon, with activity driven by emergency medical supply replenishment and broad-based generic pharmaceutical contracting. Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems (response due July 26, 2023), the City of Tampa's sealed-bid solicitation for medical and first aid supplies for the Fire Department Rescue Division with an estimated $700,000 contract value (due March 13, 2026), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products serving participating state and local facilities (due March 26, 2026). The code shows little relevant recent activity; firms pursuing pharmaceutical supply contracts should monitor broader generic pharmaceutical and emergency medical supply codes rather than this specific commodity designation.